Iterum Therapeutics Bermuda Limited., is a Bermuda exempted company limited by shares incorporated on November 6, 2019. They are a direct wholly owned finance subsidiary of the Parent; (Iterum Therapeutics plc, a public limited company formed under the laws of Ireland. Registered office located at Block 2 Floor 3, Harcourt Centre, Harcourt Street, Dublin 2, Ireland) It is intended that the Issuer will be managed and controlled in Ireland on an on-going basis. Issuer’s Registered office is located at Clarendon House, 2 Church Street, Hamilton HM11, Bermuda.

Royalty-Linked Notes in an aggregate principal amount of $103,176 were issued under an indenture, dated as of January 21, 2020, by and among the Issuer, the Guarantors, Iterum Holders’ Representative LLC, as holders’ representative, and Computershare Trust Company, N.A., as trustee, which we refer to as the Royalty-Linked Notes Indenture and additional Royalty-Linked Notes in an aggregate principal amount of $440 were issued pursuant to the Rights Offering to the holders of Parent ordinary shares as of the record date.

Iterum Therapeutics Bermuda Limited., 2,590,400 Limited Recourse Royalty-Linked Subordinated Notes aggregate principal amount of US$$103,176 due December 31, 2045.,